Preparation and In-vitro Evaluation of Sublingual Tablets of Captopril

Authors

  • Nisrin Kaddar Tishreen University
  • Ghaith Alshekh Mousa Tishreen University

Abstract

Captopril is an angiotensin converting enzyme inhibitor. It is used by sublingual route to treat hypertension crises. The sublingual route achieves a rapid onset of action compared to the oral route due to the rapid and direct absorption of the drug into the blood circulation. This study aims to prepare captopril sublingual tablets by using crosspovidone and crosscarmellose sodium as superdisintegrants. The tablets were prepared by direct compression method and several physicochemical tests were performed. All formulations showed physicochemical specifications in compliance with constitutional requirements. The results of the disintegration time and of the in vitro dissolution studies showed that the F1 formula that contains 4% crosspovidone has the lowest disintegration time of 25 seconds and releases more than 90% of the drug substance within less than 6 minutes. The results also showed the importance of the presence of mannitol in the formula.

Author Biographies

Nisrin Kaddar, Tishreen University

Associate Professor- Department of Pharmaceutics and Pharmaceutical Technology- Faculty of Pharmacy

Ghaith Alshekh Mousa, Tishreen University

Postgraduate student- Industrial Pharmacy- Department of Pharmaceutics and Pharmaceutical Technology- Faculty of Pharmacy

Downloads

Published

2022-06-16

How to Cite

1.
نسرين قدار, غيث الشيخ موسى. Preparation and In-vitro Evaluation of Sublingual Tablets of Captopril. Tuj-hlth [Internet]. 2022Jun.16 [cited 2024Apr.28];44(2):423-34. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/12694

Issue

Vol. 44 No. 2 (2022): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Master student researches

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.